Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Thymoglobulin Dose”

32 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 32 results

Testing effectiveness (Phase 2)UnknownNCT00742300
What this trial is testing

Autologous Hematopoietic Stem Cell Transplantation for Refractory Autoimmune Diseases

Who this might be right for
Autoimmune Diseases
Charite University, Berlin, Germany
Testing effectiveness (Phase 2)Active Not RecruitingNCT01985061
What this trial is testing

Evaluation of 3 Different Doses of IV Busulfan

Who this might be right for
Myelodysplastic SyndromeAcute Myeloid Leukemia
Institut Paoli-Calmettes 177
Not applicableStudy completedNCT04869254
What this trial is testing

Lymphocyte Count, ATG Dose and Incidence and Severity of GVHD in Pediatric Recipients of HSCT

Who this might be right for
Hematopoietic Stem Cell Transplantation
IRCCS Burlo Garofolo 102
Not applicableStudy completedNCT01976390
What this trial is testing

Comparing Everolimus and Sirolimus in Renal Transplant Recipients

Who this might be right for
Renal Failure
Ohio State University 60
Testing effectiveness (Phase 2)Study completedNCT00117689
What this trial is testing

Evaluation of Thymoglobulin Induction and Reduced Doses of Calcineurin Inhibitors on Liver Transplant Rejection

Who this might be right for
Liver DysfunctionRejection, TransplantTransplantation, Liver
Genzyme, a Sanofi Company 75
Post-approval studies (Phase 4)UnknownNCT02102854
What this trial is testing

Single Dose rATG for Renal Allograft Rejection

Who this might be right for
Acute (Cellular) Renal Allograft Rejection
The Methodist Hospital Research Institute 30
Testing effectiveness (Phase 2)Ended earlyNCT00409695
What this trial is testing

Thymoglobulin (ATG) Dose Finding Study

Who this might be right for
Graft vs Host Disease
M.D. Anderson Cancer Center 1
Post-approval studies (Phase 4)UnknownNCT03088280
What this trial is testing

Efficacy and Safety of Rabbit Antithymocyte Globulin 3mg/kg in Kidney Transplant Patients Under Steroid-free and CNI Minimization Maintenance Immunosuppressive Regimen

Who this might be right for
Thymoglobulin Dose
Hospital Geral de Fortaleza 200
Not applicableStudy completedNCT00970073
What this trial is testing

Low Dose Thymoglobulin to Protect Kidney Function After Liver Transplant

Who this might be right for
Liver Transplantation
The Cleveland Clinic 30
Not applicableUnknownNCT06039436
What this trial is testing

Conditioning Regimen Containing Low Dose ATG for The Treatment of Acquired SAA Receiving sUCBT

Who this might be right for
Severe Aplastic Anemia
Anhui Provincial Hospital 72
Testing effectiveness (Phase 2)Study completedNCT01490723
What this trial is testing

Zevalin-Containing Nonmyeloablative Conditioning for Stem Cell Transplantation (SCT)

Who this might be right for
LeukemiaLymphoma
M.D. Anderson Cancer Center 20
Early research (Phase 1)Study completedNCT01758328
What this trial is testing

Dose Escalation Trial of WT1-specific Donor-derived T Cells Following T-Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation for Patients With Relapsed/Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Memorial Sloan Kettering Cancer Center 29
Large-scale testing (Phase 3)UnknownNCT00934557
What this trial is testing

Randomized Study of ATG for Graft Versus Host Disease (GVHD) Prevention in Paediatric Patients Given an Unrelated Donor Stem Cell Transplantation

Who this might be right for
Paediatric Patients Affected by Haematological Malignancies and Eligible to Undergo HSCT From an Unrelated Volunteer
Fondazione IRCCS Policlinico San Matteo di Pavia 42
Not applicableUnknownNCT02028416
What this trial is testing

Comparison of Two Different Doses of Rabbit ATG-Fresenius With Cyclosporin in the Treatment of Acquired Aplastic Anaemia

Who this might be right for
Aplastic Anemia
National Institute of Blood Disease Center, Pakistan 60
Testing effectiveness (Phase 2)Active Not RecruitingNCT00716066
What this trial is testing

Autologous Stem Cell Transplant for Neurologic Autoimmune Diseases

Who this might be right for
Autoimmune DiseaseNeurologic Autoimmune DiseaseAutologous Transplant Autoimmune+16 more
Fred Hutchinson Cancer Center 53
Testing effectiveness (Phase 2)Active Not RecruitingNCT04872595
What this trial is testing

A Modified Dose of Rabbit Anti-thymocyte Globulin (rATG) in Children and Adults Receiving Treatment to Help Prepare Their Bodies for a Bone Marrow Transplant

Who this might be right for
Acute Myeloid Leukemia (AML)Acute Lymphoid Leukemia (ALL)Myelodysplastic Syndromes (MDS)
Memorial Sloan Kettering Cancer Center 59
Not applicableEnded earlyNCT00235781
What this trial is testing

Single Dose Thymoglobulin for Induction in Adult Renal Allograft Recipients

Who this might be right for
Kidney Transplantation
Washington University School of Medicine 90
Testing effectiveness (Phase 2)Study completedNCT00288626
What this trial is testing

High-Dose Immunosuppression and Autologous Transplantation for Multiple Sclerosis (HALT MS) Study

Who this might be right for
Relapsing-Remitting Multiple Sclerosis
National Institute of Allergy and Infectious Diseases (NIAID) 25
Not applicableStudy completedNCT00088543
What this trial is testing

Thymoglobulin to Prevent Acute Graft vs. Host Disease (GvHD) in Patients With Acute Lymphocytic Leukemia (ALL) or Acute Myelogenous Leukemia (AML) Receiving a Stem Cell Transplant

Who this might be right for
Acute Myelogenous Leukemia (AML)Acute Lymphocytic Leukemia (ALL)Graft vs. Host Disease (GvHD)
Genzyme, a Sanofi Company 60
Testing effectiveness (Phase 2)Study completedNCT02441803
What this trial is testing

Allogeneic Hematopoietic Stem Cell Transplantation (AlloSCT) Initial Salvage Therapy for Induction Failure Acute Myeloid Leukemia (AML)

Who this might be right for
Leukemia
M.D. Anderson Cancer Center 11
Load More Results